pillbase.ru

Rayvow

Active substance: lasmiditan

lasmiditan succinate

Centralised EU authorisationActive

Marketing holder: Eli Lilly Nederland B.V.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 2
  • Reyvow
    TABLET · LASMIDITAN 50 mg/1
    0002-4312
    Eli Lilly and Company
  • Reyvow
    TABLET · LASMIDITAN 100 mg/1
    0002-4491
    Eli Lilly and Company
Import and control

Control by country

  • United StatescontrolledSchedule: CV

    Source: openFDA NDC · record 01a1208e-af10-78be-8e90-53130ad8d343,01a1209e-0be9-7260-a7b0-7fc8e501a37f;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005332
Registration status
Active
ATC code
N02CC08
Sources
  • product · EMA · EMEA/H/C/005332 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005332 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005332 · Verified 2026-10-09